Related Experiment Video

Updated: Jun 7, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

[Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and

Masahiro Koizumi1, Masafumi Fukagawa

  • 1Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine.

Clinical Calcium
|November 2, 2010
PubMed

Insights

Sevelamer hydrochloride, a phosphate binder, effectively lowers phosphate levels and may reduce cardiovascular calcification compared to calcium-based binders. It also offers benefits in lipid metabolism and inflammation.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Context:

  • Hyperphosphatemia, common in declining kidney function, increases mortality and cardiovascular calcification risk.
  • Sevelamer hydrochloride is a non-aluminum, calcium-free phosphate binder.
  • Calcium-based binders can cause hypercalcemia, unlike sevelamer.

Purpose:

  • To evaluate sevelamer hydrochloride's efficacy and safety in managing hyperphosphatemia.
  • To compare sevelamer's effect on cardiovascular calcification versus calcium-based binders.
  • To explore sevelamer's additional pleiotropic effects on vascular health.

Summary:

  • Sevelamer hydrochloride effectively reduces serum phosphate levels, comparable to calcium-based binders.
  • Unlike calcium-based binders, sevelamer does not promote hypercalcemia.
  • Evidence suggests sevelamer may attenuate cardiovascular calcification and offers benefits in lipid metabolism and inflammation.

Impact:

  • Sevelamer hydrochloride provides an alternative phosphate binder for patients with kidney disease.
  • Potential to reduce cardiovascular complications associated with hyperphosphatemia.
  • Broader therapeutic potential beyond phosphate binding, including cardiovascular risk mitigation.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...